These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 25257919

  • 21. Long-detection interval for ICDs helps avoid harmful shocks.
    Harv Heart Lett; 2014 Nov; 25(3):8. PubMed ID: 26084067
    [No Abstract] [Full Text] [Related]

  • 22. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ.
    Cardiol J; 2013 Nov; 20(3):217-9. PubMed ID: 23788293
    [No Abstract] [Full Text] [Related]

  • 23. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Kulkarni N, Link MS.
    Card Electrophysiol Clin; 2018 Mar; 10(1):67-74. PubMed ID: 29428143
    [Abstract] [Full Text] [Related]

  • 24. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C, Yan GX, Kocovic D, Kowey PR.
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract] [Full Text] [Related]

  • 25. Conductor externalization of the RIATA implantable cardioverter defibrillator lead: a challenging lead extraction requiring laser-powered sheath.
    Migliore F, Bertaglia E, Bontempi L, Verlato R, Leoni L, Iliceto S, Curnis A.
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):755-6. PubMed ID: 23996009
    [Abstract] [Full Text] [Related]

  • 26. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D, Stros P, Curila K, Kebza V, Osmancik P.
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [Abstract] [Full Text] [Related]

  • 27. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R, Shah AJ, Keebler M, Thakur RK.
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [Abstract] [Full Text] [Related]

  • 28. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 29. The burden of inappropriate shocks in young people and how to avoid them.
    Upadhyay GA, Mela T, Singh JP.
    Heart; 2012 Oct 01; 98(19):1457-66. PubMed ID: 22965797
    [No Abstract] [Full Text] [Related]

  • 30. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G, Braunschweig F, Deharo JC, Leyva F, Lubinski A, Lazzaro C.
    Europace; 2013 Oct 01; 15(10):1453-62. PubMed ID: 23696624
    [Abstract] [Full Text] [Related]

  • 31. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G, Magnani A, Occhetta E.
    Europace; 2015 Nov 01; 17(11):1726. PubMed ID: 26462698
    [No Abstract] [Full Text] [Related]

  • 32. MY APPROACH to the patient with an infected implantable cardioverter defibrillator (ICD).
    Curtis AB.
    Trends Cardiovasc Med; 2017 Nov 01; 27(8):587-588. PubMed ID: 28992866
    [No Abstract] [Full Text] [Related]

  • 33. [About an implantable cardioverter-fibrillator].
    Douchet MP, Bakouboula B, Bronner F, Chauvin M.
    Ann Cardiol Angeiol (Paris); 2012 Aug 01; 61(4):290-1. PubMed ID: 21663891
    [Abstract] [Full Text] [Related]

  • 34. Twiddler syndrome as a rare cause of implantable cardioverter defibrillator malfunction.
    Gungor H, Duygu H, Yildiz BS, Gul I, Zoghi M, Akin M.
    J Cardiovasc Med (Hagerstown); 2009 Apr 01; 10(4):352-3. PubMed ID: 19430349
    [Abstract] [Full Text] [Related]

  • 35. Inappropriate shock due to late dislocation of electrode.
    Ruiz-Salas A, Datino T, Peña-Hernández J, Calvo D, Alzueta J.
    Int J Cardiol; 2015 Nov 15; 199():229-31. PubMed ID: 26209824
    [No Abstract] [Full Text] [Related]

  • 36. Unintentional protrusion and trapping of the screw-in helix of an implantable cardioverter defibrillator lead.
    Irie T, Kaneko Y, Nakajima T, Kurabayashi M.
    J Cardiovasc Electrophysiol; 2011 Mar 15; 22(3):351. PubMed ID: 21385262
    [No Abstract] [Full Text] [Related]

  • 37. Percutaneous removal of endocardial implantable cardioverter-defibrillator lead displaced to the right pulmonary artery.
    Małecka B, Kutarski A, Zabek A, Maziarz A, Pytkowski M.
    Cardiol J; 2010 Mar 15; 17(3):293-8. PubMed ID: 20535721
    [Abstract] [Full Text] [Related]

  • 38. Device therapy: Defibrillators-a shocking therapy for cardiomyopathy?
    Cleland JG, Buga L.
    Nat Rev Cardiol; 2010 Feb 15; 7(2):69-70. PubMed ID: 20104242
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.
    DeWitt ES, Triedman JK, Cecchin F, Mah DY, Abrams DJ, Walsh EP, Gauvreau K, Alexander ME.
    Circ Arrhythm Electrophysiol; 2014 Dec 15; 7(6):1057-63. PubMed ID: 25262116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.